|
Market Cap (4-Jul) $171,348,752 (477th) |
Close (30-Jun) $0.99 |
Volume (30-Jun) 1,077,429 |
Shortsold (19-Jun) 1,473,254 (0.38%) (338th) |
|
52w High $0.66 |
52w Low $0.165 |
P/E - |
EPS -0.05 |
PAR released this announcement to the ASX on 24 December 2021, 8:23. The announcement is not marked as price sensitive, and is 29 page(s) in length and 0.9MB in size.
You can view all announcements from PAR and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAR was 4.443% short sold according to ASIC data. It was ranked the 28th most shorted stock on the ASX. It remains ranked 338th as of the latest reported data (19 June 2025).
| Other Recent Announcements from PAR | |
|---|---|
| Notification of cessation of securities - PAR | 29 June 2023, 16:43 |
| Primary and Secondary endpoints met in MPS I Trial | 6 June 2023, 12:28 |
| iPPS shows 3-year equivalent durability in OA Canine Study | 1 June 2023, 8:21 |
| Notice of Annual General Meeting/Proxy Form | 24 December 2021, 8:23 |
| PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL | 16 December 2021, 12:29 |
| Paradigm Presentation for Investor Webinar | 2 December 2021, 10:03 |
| Paradigm Investor Webinar | 30 November 2021, 9:36 |
You must be logged in to post a reply.
Paradigm Biopharmaceuticals 